Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. [electronic resource]
Producer: 20010816Description: 78-83 p. digitalISSN:- 0007-1048
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- adverse effects
- Fatigue -- chemically induced
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Platelet Count
- Primary Myelofibrosis -- complications
- Thalidomide -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.